Effects of FK506 as a Keratinocyte Response Modifier: A Study of Molecular Mechanisms and Clinical Implications
博士 === 高雄醫學大學 === 醫學研究所博士班 === 95 === Since the approval in 2001 by U.S. Food and Drug Administration as a promising therapeutic agent for atopic dermatitis, tacrolimus (FK506) ointment, a novel topical immunomodulator, has been welcomed by the dermatologic society in general as the “drug of choice”...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2007
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/70291450904327191284 |